A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE

NCT04656613 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Collaborators